Agios Pharmaceuticals (AGIO) earnings, Nov 5, 2026: EPS +39%, stock −9.9%
In brief
Agios Pharmaceuticals reported on Nov 5, 2026. Earnings per share changed +39% year over year, 12.4% above the estimate; revenue +329%. The stock opened with a −0.6% gap and closed the day −9.9% (Nov 5, 2026). The stock is now 38.5% below its 52-week high, −30.2% over 12 months.
EPS vs estimate+12.4%
EPS, YoY+39%
Revenue, YoY+329%
Gap · day−0.6% · −9.9%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −15.8% | −6.5% |
| Nov 5, 2026 | −0.6% | −9.9% |
Next-quarter estimates, ratings and the AGIO chart are in the terminal.
Open the terminalFAQ
When is Agios Pharmaceuticals's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Agios Pharmaceuticals stock react to the report?
Opening gap −0.6%, day's result −9.9%.
Did Agios Pharmaceuticals's earnings grow?
Earnings per share rose 39% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.